| 1. | Assicot M, Gendrel D, Carsin H, et al. High serum procalcitonin concentrations in patients with sepsis and infection[J]. Lancet, 1993, 341(5): 515-518. | 
				                                                        
				                                                            
				                                                                | 2. | 孫振球. 醫學統計學[M]. 2版. 北京: 人民衛生出版社, 2005: 399-448. | 
				                                                        
				                                                            
				                                                                | 3. | Kim JH, Seo JW, Mok JH, et al. Usefulness of plasma procalcitonin to predict severity in elderly patients with community-acquired pneumonia[J]. Tuberculosis and respiratory diseases, 2013, 74(5): 207-214. | 
				                                                        
				                                                            
				                                                                | 4. | Lacoma A, Prat C, Andreo F, et al. Value of procalcitonin, C-reactive protein, and neopterin in exacerbations of chronic obstructive pulmonary disease[J]. Int J Chron Obstruct Pulmon Dis, 2011, 6: 157-169. | 
				                                                        
				                                                            
				                                                                | 5. | Hillas G, Vassilakopoulos T, Plantza P, et al. C-reactive protein and procalcitonin as predictors of survival and septic shock in ventilator-associated pneumonia[J]. Eur Respir J, 2010, 35(4): 805-811. | 
				                                                        
				                                                            
				                                                                | 6. | 劉少鋒, 楊健, 劉敏. 降鈣素原與創傷的研究進展[J]. 華西醫學, 2012, 27(5): 789-793. | 
				                                                        
				                                                            
				                                                                | 7. | Seligman R, Seligman BG, Teixeira PJ. Comparing the accuracy of predictors of mortality in ventilator-associated pneumonia[J]. J Bras Pneumol, 2011, 37(4): 495-503. | 
				                                                        
				                                                            
				                                                                | 8. | Schuetz P, Suter-Widmer I, Chaudri A, et al. Prognostic value of procalcitonin in community-acquired pneumonia[J]. Eur Respir J, 2011, 37(2): 384-392. | 
				                                                        
				                                                            
				                                                                | 9. | Boeck L, Eggimann P, Smyrnios N, et al. Midregional pro-atrial natriuretic peptide and procalcitonin improve survival prediction in VAP[J]. Eur Respir J, 2011, 37(3): 595-603. | 
				                                                        
				                                                            
				                                                                | 10. | 吳祖鳳, 汪錚, 李秀, 等. 社區獲得性肺炎住院患者血清降鈣素原與肺炎嚴重程度和預后的關系[J]. 安徽醫藥, 2011, 15(10): 1278-1280. | 
				                                                        
				                                                            
				                                                                | 11. | Christ-Crain M, Opal SM. Clinical review: the role of biomarkers in the diagnosis and management of community-acquired pneumonia[J]. Crit Care, 2010, 14(1): 203. | 
				                                                        
				                                                            
				                                                                | 12. | Stolz D, Smyrnios N, Eggimann P, et al. Procalcitonin for reduced antibiotic exposure in ventilator-associated pneumonia: a randomised study[J]. Eur Respir J, 2009, 34(6): 1364-1375. |